Denver, CO, United States of America

Myron J Levin

This inventor holds 2 USPTO granted patents. Top assignees: Merck + Co., Inc., University of Colorado. Active years: 1999-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Myron J Levin: Innovator in Medical Science

Introduction

Myron J Levin is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of medical science, particularly in the area of immunization against herpes zoster and related conditions. With a total of 2 patents, Levin's work has had a meaningful impact on public health.

Latest Patents

Levin's latest patents include a method for preventing zoster or alleviating varicella-related post-herpetic neuralgia. This method involves immunizing individuals at risk of developing herpes zoster with varicella zoster virus (VZV) antigen. Another patent focuses on alleviating varicella-related post-herpetic neuralgia through the same immunization approach. These innovations highlight his commitment to improving patient outcomes in the realm of viral infections.

Career Highlights

Throughout his career, Myron J Levin has worked with prominent organizations such as Merck & Company, Inc. and the University of Colorado. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Levin has collaborated with notable colleagues, including Gary B Calandra and Philip J Provost. These partnerships have further enriched his research and development efforts, leading to advancements in medical treatments.

Conclusion

Myron J Levin's contributions to medical science through his patents and collaborations demonstrate his dedication to improving health outcomes. His innovative methods for addressing herpes zoster and related conditions continue to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…